Change in mRNA expression after atenolol, a beta-adrenergic receptor antagonist and association with pharmacological response

Archives of Drug Information

Volumn 2, Issue 3, 2009, Pages 41-50

  Kohli, Utkarsh ^a   Grayson, Britney L ^b   Aune, Thomas M ^b   Ghimire, Laxmi V ^a   Kurnik, Daniel ^a,c,d   Stein, Michael C ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c SHEBA MEDICAL CENTER   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Atenolol; Microarray; mRNA expression

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BINDING PROTEIN; CARRIER PROTEIN; DECTIN 2; FIBROBLAST GROWTH FACTOR BINDING PROTEIN 2; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 5; KERATIN; KERATIN PSEUDOPROTEIN; MESSENGER RNA; NEUROTRANSMITTER TRANSPORTER; SMALL NUCLEAR RIBONUCLEOPROTEIN; SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE N; SMALL NUCLEOLAR RNA; SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY MEMBER 4C1; THIOREDOXIN; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; EXERCISE TEST; EXPLORATORY RESEARCH; FEMALE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC VARIABILITY; HEART RATE; HUMAN; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PRIORITY JOURNAL; SINGLE DRUG DOSE; TACHYCARDIA; UNINDEXED SEQUENCE; UPREGULATION;

EID: 77953451302     PISSN: None     EISSN: 17535174     Source Type: Journal    
DOI: 10.1111/j.1753-5174.2009.00020.x     Document Type: Article

References (28)

1. Foody JM, Farrell MH, Krumholz HM. Beta-blocker therapy in heart failure: Scientific review. JAMA 2002;287:883-9.
2. Frishman WH, Furberg CD, Friedewald WT. Beta-adrenergic blockade for survivors of acute myocardial infarction. N Engl J Med 1984;310: 830-7.
3. Hennekens CH, Albert CM, Godfried SL, Gaziano JM, Buring JE. Adjunctive drug therapy of acute myocardial infarction-Evidence from clinical trials. N Engl J Med 1996;335:1660-7.
4. Kamalesh M, Cerel A, Burger AJ. Management of atrial fibrillation. N Engl J Med 1992;327:1031-2.
5. Chrysant SG, Chrysant GS, Dimas B. Current and future status of beta-blockers in the treatment of hypertension. Clin Cardiol 2008;31:249-52.
6. Kurnik D, Li C, Sofowora GG, Friedman EA, Muszkat M, Xie HG, et al. Beta-1-adrenoceptor genetic variants and ethnicity independently affect response to beta-blockade. Pharmacogenet Genomics 2008;18:895-902.
7. Liggett SB, Cresci S, Kelly RJ, Syed FM, Matkovich SJ, Hahn HS, et al. A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Nat Med 2008;14:510-7.
8. Zhou HH, Silberstein DJ, Koshakji RP, Wood AJ. Interindividual differences in beta-receptor density contribute to variability in response to beta-adrenoceptor antagonists. Clin Pharmacol Ther 1989;45:587-92.
9. McDevitt DG. In vivo studies on the function of cardiac beta-adrenoceptors in man. Eur Heart J 1989;10(suppl B):22-8.
10. Wingrove JA, Daniels SE, Sehnert AJ, Tingley W, Elashoff MR, Rosenberg S, et al. Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis. Circ Cardiovasc Genet 2008;1:31-8.
11. Dupont WD. Statistical modeling for biomedical reaserchers: A simple introduction to the analysis of complex data. Cambridge: Cambridge Univ. Pr.; 2002.
12. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 1989;264:13963-6.
13. Nordberg J, Arner ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001;31:1287-312.
14. Mustacich D, Powis G. Thioredoxin reductase. Biochem J 2000;346:1-8.
15. Schallreuter KU, Wood JM, Ehrke C, Lemke R. Calcium transport and regulation in human primary and metastatic melanoma. Biochim Biophys Acta 1992;1160:127-33.
16. Mikkaichi T, Suzuki T, Onogawa T, Tanemoto M, Mizutamari H, Okada M, et al. Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney. Proc Natl Acad Sci USA 2004;101:3569-74.
17. Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Putz B, et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 2004;36:1319-25.
18. Bachis A, Mallei A, Cruz MI, Wellstein A, Mocchetti I. Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons. Neuropharmacology 2008;55:1114-20.
19. Jin Y, Sheikh F, Detillieux KA, Cattini PA. Role for early growth response-1 protein in alpha(1)-adrenergic stimulation of fibroblast growth factor-2 promoter activity in cardiac myocytes. Mol Pharmacol 2000;57:984-90.
20. Fehrenbach E. Multifarious microarray-based gene expression patterns in response to exercise. J Appl Physiol 2007;102:7-8.
21. Connolly PH, Caiozzo VJ, Zaldivar F, Nemet D, Larson J, Hung SP, et al. Effects of exercise on gene expression in human peripheral blood mononuclear cells. J Appl Physiol 2004;97:1461-9.
22. Buttner P, Mosig S, Lechtermann A, Funke H, Mooren FC. Exercise affects the gene expression profiles of human white blood cells. J Appl Physiol 2007;102:26-36.
23. Zieker D, Zieker J, Dietzsch J, Burnet M, Northoff H, Fehrenbach E. cDNA-microarray analysis as a research tool for expression profiling in human peripheral blood following exercise. Exerc Immunol Rev 2005;11:86-96.
24. Zieker D, Fehrenbach E, Dietzsch J, Fliegner J, Waidmann M, Nieselt K, et al. cDNA microarray analysis reveals novel candidate genes expressed in human peripheral blood following exhaustive exercise. Physiol Genomics 2005;23:287-94.
25. Whistler T, Jones JF, Unger ER, Vernon SD. Exercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjects. BMC Physiol 2005;5:5.
26. Feezor RJ, Baker HV, Mindrinos M, Hayden D, Tannahill CL, Brownstein BH, et al. Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol Genomics 2004;19:247-54.
27. Tanriverdi K, Freeman JE. The promise and limitation of gene expression analysis. Circ Cardiovasc Genet 2008;1:7-9.
28. Loring JF. Evolution of microarray analysis. Neurobiol Aging 2006;27:1084-6.